Company / Free Cash Flow per Share
Ligand Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$2.56
FY2025
5-year range
$2.56 / $7.15
FY2021-FY2025
Trend
-52.8%
vs FY2024
Sector context
#31 of 192
Health Care
What the data says
Ligand Pharmaceuticals, Inc.'s free cash flow per share of $2.56 is higher than 84% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.54 in FY2019 to $9.13 in FY2018.
Based on SEC 10-K filings.
2.56 in FY2025 with a 5-year CAGR of -3.0%. Top quartile in the Health Care sector.
Declined from $2.72 to $2.56 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -29.0%
- 5-Year CAGR
- -3.0%
- 10-Year CAGR
- -
Sector benchmark
+112.9% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 52.8% year-over-year.
- Ranks #31 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2018.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.56 | -52.8% |
| FY2024 | $5.42 | +99.6% |
| FY2023 | $2.72 | -62.0% |
| FY2022 | $7.15 | +64.2% |
| FY2021 | $4.36 | +46.2% |
| FY2020 | $2.98 | +294.0% |
| FY2019 | -$1.54 | -116.8% |
| FY2018 | $9.13 | +121.0% |
| FY2017 | $4.13 | +40.0% |
| FY2016 | $2.95 | +38.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026